[The meso-caval shunt--a future standard operation?]

Area of Science:

• Hepatology
• Vascular Surgery

Context:

• Portal hypertension management has evolved, emphasizing asymptomatic intervention and shunts that reduce pressure while preserving liver perfusion.
• Distal shunt operations are preferred, with the mesocaval (H-) shunt identified as optimal for meeting these criteria.

Purpose:

• To evaluate the efficacy and advantages of the mesocaval (H-) shunt procedure using expanded polytetrafluoroethylene (ePTFE) grafts for treating portal hypertension.

Summary:

• The mesocaval H-shunt, utilizing a stable, negatively charged ePTFE vascular prosthesis (e.g., Gore-TEX), effectively reduces portal hypertension.
• Advantages over splenorenal shunts include minimal operative stress, technical simplicity, reduced mortality, and lower risks of re-bleeding and encephalopathy.
• This technique is suitable for both elective and emergency interventions, even in high-risk patients.

Impact:

• The mesocaval ePTFE shunt procedure shows promise as a leading surgical option for portal hypertension, offering improved patient outcomes.
• This approach may significantly reduce complications associated with portal hypertension, enhancing the quality of life for affected individuals.